Markets
LEGN

Legend Biotech Corporation Q3 Loss Decreases

November 12, 2025 — 07:42 am EST

Written by RTTNews.com for RTTNews->

(RTTNews) - Legend Biotech Corporation (LEGN) reported Loss for third quarter of -$39.69 million

The company's earnings came in at -$39.69 million, or -$0.11 per share. This compares with -$125.32 million, or -$0.34 per share, last year.

Excluding items, Legend Biotech Corporation reported adjusted earnings of -$18.78 million or -$0.05 per share for the period.

The company's revenue for the period rose 70.0% to $272.33 million from $160.21 million last year.

Legend Biotech Corporation earnings at a glance (GAAP) :

-Earnings: -$39.69 Mln. vs. -$125.32 Mln. last year. -EPS: -$0.11 vs. -$0.34 last year. -Revenue: $272.33 Mln vs. $160.21 Mln last year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

LEGN

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.